GRCE · Grace Therapeutics, Inc. · Executive Compensation
Market Cap
$40.60M
Shares
21.04M
Volume · Oct 23
47.23K
Avg daily vol (3M)
162.26K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2026
| Executive | Role | Total |
|---|---|---|
| Prashant Kohli | Chief Executive Officer | $1,270,820 |
| Amresh Kumar | Vice President, Program Management | $465,650 |
| Carrie D’Andrea | Former Vice President, Clinical Operations | $465,650 |
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Prashant Kohli | Chief Executive Officer | $1,074,621 |
| Amresh Kumar | Vice President, Program Management | $421,563 |
| Carrie D’Andrea | Vice President, Clinical Operations | $421,563 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Prashant Kohli | Chief Executive Officer | $987,630 |
| Carrie D’Andrea | Vice President, Clinical Operations | $383,000 |
| Amresh Kumar | Vice President, Program Management | $378,019 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Carrie D’Andrea | Vice President of Clinical Operations | Terminated | 2026-06-05 |
| Edward Neugeboren | director | Appointed | 2024-09-30 |
| Prashant Kohli | director | Appointed | 2024-09-30 |
| S. George Kottayil | director | Appointed | 2024-09-30 |
| A. Brian Davis | director | Appointed | 2024-09-30 |
| Vimal Kavuru | director | Appointed | 2024-09-30 |
| Brian Ford | interim-Chief Financial Officer | Terminated | 2024-01-08 |
| Robert J. DelAversano | principal accounting officer | Appointed | 2024-01-08 |
| Robert J. DelAversano | principal financial officer | Appointed | 2024-01-08 |
| George Kottayil | Chief Operating Officer (US) | Terminated | 2023-05-11 |
| Brian Ford | Chief Financial Officer | Terminated | 2023-05-11 |
| Pierre Lemieux | Chief Operating Officer (Canada) | Terminated | 2023-05-11 |
| Carrie D'Andrea | VP Clinical Operations | Appointed | 2023-05-11 |
| Amresh Kumar | VP of Program Management | Appointed | 2023-05-11 |
| Dr. R. Loch Macdonald | Chief Medical Officer | Appointed | 2023-05-11 |
| Prashant Kohli | Chief Executive Officer | Appointed | 2023-04-05 |
| Jean-Marie (John) Canan | board of directors | Resigned | 2023-03-31 |
| Vimal Kavuru | director | Appointed | 2022-09-29 |
| Donald Olds | director | Appointed | 2022-09-29 |
| Michael L. Derby | director | Appointed | 2022-09-29 |
| Jan D'Alvise | director | Appointed | 2022-09-29 |
| Jean-Marie (John) Canan | director | Appointed | 2022-09-29 |
Leadership
- Prashant Kohli CEO, Board Member
- Robert J. DelAversano CFO, Chief Accounting Officer
- A. Brian Davis Board Member
- Donald Olds Board Member
- Edward Neugeboren Board Member
- Jan D'Alvise Board Member
- Jan D’Alvise Board Member
- Jean Marie (John) Canan Board Member
- Jean-Marie (John) Canan Board Member
- Michael L. Derby Board Member
- Roderick N. Carter Board Member
- S. George Kottayil Board Member
- Vimal Kavuru Board Member
- William A. Haseltine Board Member